A. Lategan

447 citations
11 papers · 387 indexed · h-index 5

A. Lategan

11 papers receiving 379 citations

Peers

A. Lategan
Comparison fields: 5 of 47
  • Cellular and Molecular Neuroscience 311
  • Neurology 171
  • Neurology 35
  • Biological Psychiatry 10
  • Behavioral Neuroscience 11
Replace M. Mavridis with:
M. Mavridis France
W.A. Rocca Italy
L Bassi Italy
Sharon Bledsoe United States
W.C. Graham United Kingdom
Anthony E. Kinney United States
S. Sbrenna Italy
Corinne Y. Ostock United States
S. Kuo United States
Ana Teresa Simões Portugal
A. Lategan relative to M. Mavridis France M. Mavridis's profile →
Citations per field
00.5×1.5×
M. Mavridis · 1×
Citations per year

Countries citing papers authored by A. Lategan

Since Specialization
Citations

This map shows the geographic impact of A. Lategan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lategan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lategan more than expected).

Fields of papers citing papers by A. Lategan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lategan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lategan. The network helps show where A. Lategan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A. Lategan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Lategan Line = papers co-authored together A. Lategan links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1 20231
2 20211
3 20202
4
Vinorelbine and cisplatin in advanced squamous cell carcinoma of the cervix: the South African experience.
20054
5 19973
6 19971
7 19921
8 199272
9 1991181
10 1990108
11 198913

About A. Lategan

A. Lategan is a scholar working on Otorhinolaryngology, Neurology, Oncology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 387 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (4 papers), Oral health in cancer treatment (3 papers), Neurological disorders and treatments (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Head and Neck Cancer Studies (3 papers), Attention Deficit Hyperactivity Disorder (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (311 citations), Neurology (171 citations), Neurology (35 citations), Biological Psychiatry (10 citations) and Behavioral Neuroscience (11 citations). A. Lategan has collaborated with scholars based in France, South Africa and Australia. Frequent co-authors include Françis C. Colpaert, Marc Marien, M. Marien, A.‐D. Degryse, M. Mavridis, Wouter Koek, Geoffrey Falkson, Carla I. Falkson, L. Goedhals and A. Gudgeon. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology, Clinical Neuropharmacology and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026